あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/03/26 | 日証協 | 56,460株 | -49.7% | 126,860株 | -5.38% | 104,537株 | -68.48% | 15,601株 | -79.34% |
2021/03/19 | 日証協 | 112,250株 | +142.45% | 134,079株 | +37.41% | 331,602株 | +5.43% | 75,502株 | -48.67% |
2021/03/12 | 日証協 | 46,299株 | +75.16% | 97,573株 | +143.32% | 314,525株 | +17.3% | 147,100株 | +6.42% |
2021/03/05 | 日証協 | 26,432株 | -2.46% | 40,100株 | -4.52% | 268,131株 | +12.28% | 138,224株 | +54.28% |
2021/02/26 | 日証協 | 27,100株 | +6.27% | 42,000株 | +103.86% | 238,803株 | +7.28% | 89,592株 | -25.09% |
2021/02/19 | 日証協 | 25,500株 | -44.45% | 20,602株 | -30.64% | 222,599株 | +21.77% | 119,592株 | +224.07% |
2021/02/12 | 日証協 | 45,904株 | -13.3% | 29,704株 | -43.53% | 182,803株 | -0.45% | 36,903株 | -60.57% |
2021/02/05 | 日証協 | 52,946株 | +3.12% | 52,606株 | +85.26% | 183,638株 | +6.25% | 93,602株 | +10.78% |
2021/01/29 | 日証協 | 51,342株 | -36.02% | 28,396株 | -41.45% | 172,834株 | -4.64% | 84,492株 | +6.68% |
2021/01/22 | 日証協 | 80,242株 | -58.57% | 48,500株 | +186.98% | 181,241株 | -36.15% | 79,199株 | +7.04% |
2021/01/15 | 日証協 | 193,680株 | -1.68% | 16,900株 | +31.01% | 283,872株 | +5.97% | 73,992株 | +75.63% |
2021/01/08 | 日証協 | 196,980株 | -7.43% | 12,900株 | -49.81% | 267,872株 | +0.65% | 42,130株 | -68.01% |
2020/12/30 | 日証協 | 212,780株 | -2.34% | 25,700株 | -46.9% | 266,134株 | +47.09% | 131,696株 | +112.44% |
2020/12/25 | 日証協 | 217,880株 | -2.72% | 48,400株 | +148.21% | 180,934株 | -5.84% | 61,992株 | +25.26% |
2020/12/18 | 日証協 | 223,980株 | -5.87% | 19,500株 | -73.1% | 192,163株 | +14.39% | 49,492株 | -26.52% |
2020/12/11 | 日証協 | 237,939株 | -3.6% | 72,500株 | +113.86% | 167,993株 | +0.51% | 67,351株 | +31.57% |
2020/12/04 | 日証協 | 246,816株 | +1.28% | 33,900株 | -8.81% | 167,134株 | +5.42% | 51,192株 | -25.23% |
2020/11/27 | 日証協 | 243,693株 | +0.03% | 37,177株 | +37.18% | 158,535株 | +5.04% | 68,466株 | +15.07% |
2020/11/20 | 日証協 | 243,616株 | -21.57% | 27,100株 | -76.12% | 150,929株 | -16.39% | 59,501株 | +52.97% |
※株式分割は考慮していませんのでご注意ください。
Page Top